ARCHIVES

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Orlando Health President Mark Rohl We Opted For A Florida-Centric Strategy

January 10, 2014

List of core grants renewed in FY 2003, full list of center grants.

January 16, 2004

Is More Better? ASCO Plenary Session Opens Debate On High-Dose Chemotherapy

May 28, 1999

GM Cancer Research Foundation Awards $750,000 To Five Scientists For Their Work

June 8, 2001

NEW OIG Awards Bring Total to 58

November 13, 1987

COG Begins Phase III Trial To Prevent Hearing Loss

May 30, 2008